Medical oncologist Dr. Luis Paz-Ares MD, Ph.D joins Leadartis´ scientific advisory board

10-12-2018

Luis Paz-Ares MD, PhD. Chair of the Medical Oncology Department at the Hospital 12 de Octubre, Associate, Professor at the Universidad Complutense and Head of the Lung Cancer Unit at the CNIO (National Oncology Research Center) in Madrid, Spain recently has joined Leadartis´ scientific advisory board. He graduated in Medicine and completed his PhD at the Universidad Autonoma Madrid (UAM). He was a postdoctoral ESMO Research Fellow in Medical Oncology at the Beatson Oncology Centre, University of Glasgow, Scotland; chair of the Medical Oncology Department at the Virgen del Rocío University Hospital in Seville, Head of the early clinical studies at the 12 de Octubre and Visiting Research Fellow at the Dana-Farber Cancer Institute in Boston, USA. Luis’s research focuses on lung cancer and new therapeutics; he has published over 200 articles in peer review journals, served as a member of several committees, including ASCO, ESMO, European Organisation of Cancer Protocol Review & the Spanish European Medicines Agency.

Latest News

LeadArtis to present at the final Chemostart pitching initiative in recognition of its highly innovative R&D activity
31-01-2019
The Chemostart initiative (sponsored by the Chemo company) launched in 2018 as a call for...
LeadArtis project finalist of the Kaertor and J&J innovation award in recognition of its highly innovative R&D activity
08-11-2018
The Kærtor Foundation together with Janssen (a Johnson & Johnson company) launched in 2018...
Leadartis discloses the project: ATTACK-Cancer immunotherapy by bispecific antibodies that recruit T lymphocytes
11-12-2018

LeadArtis is pleased to announce its participation as coordinator of the ATTACK project (Cancer...